STK4 (also termed MST1) is a stress-activated kinase encoded by the STK4 gene. It belongs to the STE20 family of serine/threonine kinases and functions as a core component of the Hippo pathway. This pathway regulates cell proliferation, apoptosis, and tumor suppression by phosphorylating downstream effectors like LATS1/2, which inactivate oncoproteins YAP1 and TAZ .
Structure: The full-length STK4 protein contains a catalytic kinase domain and a regulatory SARAH domain, enabling dimerization and interaction with adaptor proteins like SAV1 .
Activation Mechanism: Autophosphorylation at Thr183 in the activation loop drives kinase activity. This process occurs via intramolecular phosphorylation within dimerized STK4 molecules .
Recombinant Chlorocebus aethiops (African green monkey) STK4 is produced using diverse expression platforms to suit experimental needs:
Purity: >90% (SDS-PAGE verified) .
Stability: Maintains activity for 2–4 weeks at 4°C or longer at -20°C with cryoprotectants like glycerol .
Recombinant STK4 undergoes autoactivation via Thr183 phosphorylation, triggering caspase-mediated cleavage to generate a 36 kDa catalytic fragment that induces chromatin condensation and DNA fragmentation .
Co-expression with regulatory proteins like RASSF1A or NORE1A suppresses autophosphorylation, while membrane-targeting motifs (e.g., myristoylation) enhance it .
STK4 forms a complex with SAV1 to phosphorylate LATS1/2, inhibiting YAP1/TAZ oncoproteins .
Inactive STK4 localizes to nuclear speckles, but its activation redistributes downstream effectors, altering cytoskeletal dynamics .
Recombinant STK4 is utilized in:
Chlorocebus aethiops (African green monkey, also known as savanna monkey, green monkey, tantalus monkey, grivet monkey, or vervet monkey) STK4, also designated as MST1 (Mammalian Sterile 20-like kinase 1), is a stress-activated, pro-apoptotic serine/threonine kinase crucial in cellular regulation . As a key component of the Hippo signaling pathway, STK4 plays pivotal roles in:
Organ size control and tumor suppression through restriction of proliferation and promotion of apoptosis
Chromatin condensation and DNA fragmentation following caspase-cleavage
Phosphorylation of multiple substrates including histone H2B (H2BS14ph) during apoptosis
Phosphorylation of FOXO3 upon oxidative stress, leading to nuclear translocation and cell death initiation
Regulation of cardiac function through phosphorylation of TNNI3 (cardiac Tn-I)
The African green monkey represents an important model organism for biomedical research, with STK4 studies providing insights into both basic biological processes and potential therapeutic applications .
STK4 serves as a central component in the Hippo signaling cascade, which controls organ size and suppresses tumor formation. The pathway operates through the following mechanism:
STK4/MST1 forms a complex with its regulatory protein SAV1
This complex phosphorylates and activates LATS1/2 kinases, which are in complex with their regulatory protein MOB1
Activated LATS1/2 then phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ
Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus, preventing regulation of genes involved in cell proliferation, death, and migration
This cascade is crucial for tissue homeostasis, with STK4/MST1 acting as a tumor suppressor by repressing proliferation of mature hepatocytes, preventing activation of facultative adult liver stem cells (oval cells), and inhibiting tumor formation .
African green monkeys have been established as robust models for various diseases, including respiratory conditions. These monkeys support strong viral replication and develop pronounced respiratory disease that may more accurately reflect human conditions than other non-human primate species . When studying STK4 in these models, researchers should consider age-related variables, as exemplified by a case involving a two-month-old male African green monkey (Chlorocebus aethiops sabaeus) .
Cell-based approaches using African green monkey-derived cells provide more accessible systems for molecular studies while maintaining species-specific characteristics.
When designing experiments to study the kinase activity of recombinant Chlorocebus aethiops STK4, researchers should implement a systematic framework:
Experimental design framework:
Control groups: Include kinase-dead mutants as negative controls and constitutively active variants as positive controls
Technical replicates: Implement a minimum of three technical replicates per experimental condition
Biological replicates: Use at least three independent protein preparations
Randomization: Randomize the order of sample processing and analysis to prevent systematic bias
Blinding: When possible, blind researchers to sample identity during analysis and data collection
Kinase activity assay design:
In vitro kinase assays: Use purified recombinant STK4 with defined substrates and ATP
Cellular assays: Monitor phosphorylation of endogenous substrates in cellular contexts
Quantification methods: Implement multiple orthogonal methods (e.g., radiometric assays, phospho-specific antibodies, mass spectrometry)
For optimal experimental design, follow structured inquiry approaches that allow for clearly defined variables and controls . This is particularly important when working with complex signaling pathways like the Hippo pathway, where STK4 interacts with multiple partners and substrates .
Optimizing the expression and purification of recombinant Chlorocebus aethiops STK4 requires careful consideration of multiple factors:
Expression systems selection:
Bacterial systems: E. coli BL21(DE3) or derivatives for high yield, though these may lack post-translational modifications
Insect cell systems: Sf9 or High Five cells using baculovirus expression for improved folding and modifications
Mammalian systems: HEK293 or CHO cells for authentic post-translational modifications
Expression optimization strategies:
Test multiple fusion tags (His6, GST, MBP) for improved solubility and purification
Optimize induction conditions (temperature, inducer concentration, duration)
Consider co-expression with chaperones or binding partners for improved folding
Test expression of kinase domain alone versus full-length protein
Purification approach:
Initial capture using affinity chromatography based on fusion tag
Intermediate purification using ion exchange chromatography
Polishing step using size exclusion chromatography
Quality control via SDS-PAGE, Western blot, and activity assays
Critical considerations:
Maintain kinase in active state throughout purification
Include phosphatase inhibitors if preserving phosphorylation states
Optimize buffer conditions for stability (glycerol, reducing agents)
Consider stability testing for storage conditions
Applying these systematic approaches ensures production of high-quality recombinant STK4 suitable for downstream applications.
Studying the dynamic localization and translocation of STK4 requires appropriate imaging and biochemical techniques:
Imaging approaches:
Live-cell imaging: Using fluorescent protein fusions (GFP-STK4) for real-time monitoring
Immunofluorescence microscopy: Using STK4-specific antibodies in fixed cells
Confocal imaging: For high-resolution localization studies, similar to techniques used in structured inquiry exercises with Drosophila GAL4 enhancer trap strains
Biochemical fractionation:
Subcellular fractionation (cytoplasmic, nuclear, membrane fractions)
Western blotting of fractionated samples
Protease protection assays for membrane topology
Stimulus-induced translocation studies:
Monitor STK4 localization under stress conditions (oxidative stress, DNA damage)
Time-course analysis of translocation events
Pharmacological manipulations to modulate translocation
For immunohistochemistry studies, researchers can follow protocols similar to those used in other model systems, which include tissue fixation, antibody staining, and confocal imaging . When analyzing confocal images, quantification of colocalization with cellular markers is essential for determining the subcellular distribution of STK4 under different conditions.
CRISPR/Cas9 technology provides powerful approaches for studying STK4 function in African green monkey cells:
Genome editing strategies:
Knockout studies: Complete elimination of STK4 expression
Knockin approaches: Introduction of tags, reporters, or specific mutations
Base editing: For precise nucleotide modifications without double-strand breaks
Based on successful CRISPR/Cas9-mediated knock-in approaches in other systems, researchers should consider:
Designing guide RNAs targeting the STK4 locus
Preparing an HDR template with 150-200 bp homology arms flanking the insertion site
Using chemically modified dsDNA HDR templates (such as IDT's Alt-R HDR Donor Blocks) and small molecule HDR enhancers to improve efficiency
Implementing a 3-primer PCR strategy for genotyping edited cells to estimate heterozygosity and mosaicism levels
For optimal results, researchers should:
Design multiple guide RNAs to target different regions of the gene
Test delivery methods including plasmid transfection, viral vectors, and ribonucleoprotein complexes
Include appropriate controls including non-targeting guides
Validate editing outcomes through sequencing and functional assays
This approach enables precise modification of the STK4 gene for detailed functional studies, including reporter gene insertion for visualization of expression patterns .
Identifying and characterizing the phosphorylation targets of STK4 requires a multi-faceted analytical approach:
Phosphoproteomic analysis:
Mass spectrometry-based approaches: LC-MS/MS analysis of enriched phosphopeptides
Phospho-enrichment methods: IMAC (Immobilized Metal Affinity Chromatography), TiO2 chromatography, phospho-specific antibody immunoprecipitation
Quantitative strategies: SILAC, TMT, or label-free quantification
Validation methods:
In vitro kinase assays: Using purified substrates to confirm direct phosphorylation
Phospho-specific antibodies: For immunoblotting and immunofluorescence detection of phosphorylated substrates
Mutagenesis studies: Site-directed mutagenesis of predicted phosphorylation sites
Functional assays: Cellular assays to assess the impact of phosphorylation on substrate function
| Technique | Advantages | Limitations | Applications |
|---|---|---|---|
| Phosphoproteomics | Unbiased, global analysis | Expensive, complex sample prep | Discovery of novel targets |
| In vitro kinase assays | Direct evidence of kinase activity | Artificial conditions | Validation of specific substrates |
| Phospho-antibodies | Detection in cellular context | Specificity issues | Monitoring phosphorylation in vivo |
| Mutagenesis | Functional significance | Labor intensive | Confirming critical sites |
For comprehensive characterization, implement an integrated analytical workflow that begins with unbiased discovery and progresses through multiple validation steps to confirm physiologically relevant STK4 substrates.
Analysis and interpretation of complex data from STK4 signaling studies require robust statistical and computational approaches:
Statistical analysis approaches:
Apply appropriate statistical tests based on experimental design and data distribution
Implement multiple comparison corrections for large-scale data
Consider power analysis to ensure adequate sample sizes
Data integration methods:
Pathway analysis using established databases (KEGG, Reactome)
Network analysis to identify signaling hubs and interactions
Multi-omics integration when combining transcriptomic, proteomic, and functional data
Temporal analysis for time-course experiments
For complex signaling networks like those involving STK4, researchers should consider developing carefully designed databases that compile individual datasets and capture relationships between elements, facilitating investigation of associations among various components of the signaling pathway .
When confronted with contradictory results in STK4 functional studies, implement a systematic troubleshooting approach:
Sources of variability to consider:
Cellular context: Different cell types or tissue origins
Experimental conditions: Variations in protocols, reagents, or environmental factors
Genetic background: Species or strain differences, genetic modifications
Protein isoforms: Alternative splicing or post-translational modifications
Assay sensitivity and specificity: Different detection methods or readouts
Systematic approach to resolution:
Replicate experiments: Verify reproducibility under identical conditions
Vary experimental parameters: Systematically test conditions to identify critical variables
Use orthogonal methods: Apply independent techniques to address the same question
Control for confounding factors: Identify and eliminate potential confounders
Consider biological complexity: Evaluate context-dependency of results
As noted in experimental design literature, "The design must reflect the question that is being asked, the limitations of the experimental system, and the methods that will be used to analyze the data. Many experiments using global profiling approaches have been compromised by inadequate consideration of experimental design issues" . This principle applies directly to resolving contradictory results in STK4 studies.
Antibody-based studies of STK4 face several technical challenges that require specific strategies to overcome:
Common challenges:
Specificity issues: Cross-reactivity with related kinases (STK3/MST2)
Sensitivity limitations: Detecting low expression levels or specific phosphorylation states
Batch-to-batch variability: Inconsistent performance between antibody lots
Application limitations: Antibodies that work for Western blot but not immunoprecipitation
Validation strategies:
Genetic controls: Testing in knockout or knockdown systems
Peptide competition: Confirming specificity using blocking peptides
Multiple antibodies: Using different antibodies targeting distinct epitopes
Recombinant protein standards: Including positive controls
Based on information from antibody resources, researchers should select validated antibodies that have been tested in multiple applications relevant to their experimental design . For example, when selecting anti-Serine/threonine-protein kinase 4/MST-1 antibodies, researchers should verify suitability for specific applications such as immunoprecipitation (IP), Western blotting (WB), immunocytochemistry/immunofluorescence (ICC/IF), flow cytometry, and immunohistochemistry (IHC-P) .
Rigorous experimental design for STK4 inhibition or activation studies requires comprehensive controls:
For inhibition studies:
Negative controls: Vehicle treatment, inactive analog compounds
Positive controls: Known effective inhibitors, genetic knockdown/knockout
Specificity controls: Testing effects on related kinases
Dose-response analysis: Multiple concentrations to establish IC50
Time-course analysis: Determine optimal treatment duration
Off-target validation: Testing for known off-target effects
For activation studies:
Baseline measurements: Untreated/unstimulated conditions
Positive controls: Known activators or constitutively active mutants
Negative controls: Kinase-dead mutants, inhibitor pre-treatment
Dose-response relationships: Multiple stimulus intensities
Time-course analysis: Activation kinetics and duration
Downstream validation: Confirmation of effector activation
Investigating signaling cross-talk involving STK4 requires integrated experimental approaches:
Experimental strategies:
Simultaneous pathway monitoring: Multi-parameter readouts of multiple pathways
Sequential pathway perturbation: Temporal manipulation of pathway activation
Combinatorial inhibition/activation: Systematic perturbation of multiple pathways
Genetic interaction studies: Combinatorial genetic modifications
Technical approaches:
Phosphoproteomics: Global analysis of phosphorylation changes
Protein-protein interaction studies: Immunoprecipitation, proximity labeling
Transcriptional profiling: RNA-seq under various pathway modulation conditions
Single-cell analysis: Examining pathway heterogeneity and correlation
Based on STK4's known interactions, researchers should focus on cross-talk with pathways including:
p53 pathways, as STK4 phosphorylates SIRT1 and inhibits p53/TP53 deacetylation
AR signaling, as STK4 phosphorylates AR on 'Ser-650' and suppresses its activity
These interconnected pathways suggest complex regulatory networks that require systematic investigation to fully understand STK4's role in cellular homeostasis.
For investigating STK4's role in disease pathogenesis, researchers should implement a multi-faceted approach:
Model selection considerations:
Cellular models: Primary cells from African green monkeys or relevant tissues
Organoid models: 3D culture systems that recapitulate tissue architecture
Animal models: African green monkeys have been established as robust models for various diseases
Patient samples: Analysis of clinical specimens for comparison with model systems
Disease-specific methodologies:
Cancer: Focus on proliferation, apoptosis resistance, migration, in vivo tumorigenesis
Immune disorders: Immune cell function, cytokine production, inflammation
Metabolic diseases: Metabolic profiling, glucose tolerance, insulin sensitivity
Respiratory diseases: African green monkeys support robust viral replication and develop pronounced respiratory disease
Given STK4's role in the Hippo pathway and its function in organ size control and tumor suppression, cancer models represent particularly relevant systems for studying its function. The protein's involvement in regulating apoptosis and cell proliferation suggests its potential significance in diverse pathological conditions .
For maximum translational relevance, disease models should be carefully selected to reflect the specific pathological context being investigated, with appropriate controls and validation approaches.